Note: Ingredients listed on restricted chemical lists
EC/CAS
215-222-5/1314-13-2
Name of the chemical
Zinc oxide; C.I. 77947
Concentration
10 - 30
EC/CAS
215-609-9/1333-86-4
Name of the chemical
carbon black
Concentration
25
General Information
Version
1.5
Revision date
2024-03-01
Product name
RS-GCS-027-SM5 SILICONE THERMAL GREASE
1.2.1 Relevant identified uses
Professional use
supplier name
RS Components Ltd
Emergency telephone
+44 (0) 1865 407333, +44 1235 239670, +353 (0)1 809 2166
Icons in SDS
Company Information
company name
RS Components Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
RCustomerServicesUK@rs-components.com, enquiries.ie@rs-components.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351, H400, H410
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Very toxic to aquatic life with long lasting effects. Very toxic to aquatic life.
2.2 Label elements
Labelling
Hazard pictograms
GHS08 GHS09
Signal word
Warning
Contains
CARBON BLACK MESOPOROUS
Hazard statements
H351 - Suspected of causing cancer (oral). H410 - Very toxic to aquatic life with long lasting effects.
Precautionary statements
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P273 - Avoid release to the environment. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P308+P313 - IF exposed or concerned: Get medical advice/attention. P391 - Collect spillage. P405 - Store locked up. P501 - Dispose of contents and container to a hazardous or special waste collection point.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %